Biagi Giuliana, Giorgi Irene, Livi Oreste, Pacchini Federica, Rum Pietro, Scartoni Valerio, Costa Barbara, Mazzoni Maria Rosa, Giusti Laura
Department of Pharmaceutical Sciences, University of Pisa, Italy.
Farmaco. 2002 Mar;57(3):221-33. doi: 10.1016/s0014-827x(02)01200-4.
erythro-2-Phenyl-9-(2-hydroxy-3-nonyl)adenine and its 8-aza analog were prepared and showed a very high inhibitory activity towards adenosine deaminase (ADA), with Ki 0.55 and 1.67 nM, respectively, and high affinity for A1 adenosine receptors, with Ki 28 and 2.8 nM, respectively. To increase affinity for A1 receptors we introduced a substituent on the N6 position such as alkyl or cycloalkyl groups, which are present in effective agonists or antagonists. Furthermore, for some compounds, we prepared the two diastereoisomers erythro and threo to verify whether the binding with A1 receptors is stereoselective, as in ADA. Results show that some of the synthesised compounds are good inhibitors for ADA and good ligands for A1, and the erythro diastereoisomers are more active than the threo ones. The experimental evidence allows us to hypothesise some similarity in the three dimensional structures of the binding site of the two proteins, ADA and A1 adenosine receptor, in spite of lacking any homologies in the amino acid sequences.
制备了赤藓糖型-2-苯基-9-(2-羟基-3-壬基)腺嘌呤及其8-氮杂类似物,它们对腺苷脱氨酶(ADA)表现出非常高的抑制活性,其抑制常数(Ki)分别为0.55和1.67 nM,并且对A1腺苷受体具有高亲和力,其Ki分别为28和2.8 nM。为了增加对A1受体的亲和力,我们在N6位引入了一个取代基,如烷基或环烷基,这些基团存在于有效的激动剂或拮抗剂中。此外,对于一些化合物,我们制备了赤藓糖型和苏阿糖型两种非对映异构体,以验证与A1受体的结合是否像与ADA结合那样具有立体选择性。结果表明,一些合成化合物是ADA的良好抑制剂和A1的良好配体,并且赤藓糖型非对映异构体比苏阿糖型更具活性。实验证据使我们能够推测,尽管两种蛋白质(ADA和A1腺苷受体)的氨基酸序列缺乏任何同源性,但它们结合位点的三维结构存在一些相似性。